Skip to main content

Assistant Professor, Division of Infectious Diseases

Specialty Areas

Infectious diseases of immunocompromised patients.

Dr. Andermann’s research focus on how intestinal microbiome-host interactions impact infectious complications and other outcomes in patients with hematologic malignancies. Her goal is to develop microbiome-targeted therapies for the prevention and treatment of infectious diseases in these and other immunocompromised patient populations.


BA: University of California at Santa Cruz, 2002; MPH: University of California at Berkeley, 2008; MD: Stanford School of Medicine, 2010; Resident: Stanford University Hospital, 2010-2013; Infectious Diseases Fellowship: Stanford University Hospital, 2013-2019; Assistant Professor of Medicine: University of North Carolina, 2019-present.

Personal Statement

I am an Infectious Diseases physician specializing in the care of patients with compromised immune systems. I work together with a team of physicians and health professionals to provide the best and most compassionate care possible to those patients with cancer or who have undergone transplantation.


  • Senchyna F, Gaur R, Sandlund J, Truong C, Tremintin G, Kueltz D, Gomez C, Tamburini F, Andermann TM, Bhatt AS, Tickler IA, Watz N, Budvytiene I, Shi G, Tenover FC, Banaei N. Diversity of Resistance Mechanisms in Carbapenem-Resistant Enterobacteriaceae at a Health Care System in Northern California, from 2013 to 2016. Diagnostic Microbiology and Infectious Disease, doi: 10.1016/j.diagmicrobio.2018.10.004.
  • Tamburini FB*, Andermann TM*, Tkachenko E, Senchyna F, Banaei N, Bhatt AS. Precision Identification of Diverse Bloodstream Pathogens in the Gut Microbiome. Nature Medicine, 2018. doi: 10.1038/s41591-018-0202-8. *Co-primary authors.

Featured in:

    1. The NIH Director’s Blog:
    2. Medscape:
  • Andermann TM, Peled JU, Ho C, et al. The Microbiome and Hematopoietic Stem Cell Transplant: Past, Present, and Future. Biology of Blood and Marrow Transplant, 2018. doi:10.1016/j.bbmt.2018.02.009.
  • Andermann TM, Bhatt AS. Antibiotics in Hematopoietic Cell Transplantation: Adversaries or Allies? Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant, 2016. doi:10.1016/j.bbmt.2016.04.002.
  • Collins KD, Andermann TM, Draper J, et al. The Helicobacter pylori CZB Cytoplasmic Chemoreceptor TlpD Forms an Autonomous Polar Chemotaxis Signaling Complex That Mediates a Tactic Response to Oxidative Stress. J Bacteriol, 2016. doi:10.1128/JB.00071-16.
  • Andermann TM, Rezvani A, Bhatt AS. Microbiota Manipulation With Prebiotics and Probiotics in Patients Undergoing Stem Cell Transplantation. Curr Hematol Malig Rep, 2016. doi:10.1007/s11899-016- 0302-9.
  • Sanders L, Andermann TM, Ottemann KM. A supplemented soft agar chemotaxis assay demonstrates the Helicobacter pylori chemotactic response to zinc and nickel. Microbiol, 2013. doi:10.1099/mic.0.062877-0.
  • Williams SM, Chen Y-T, Andermann TM, Carter JE, McGee DJ, Ottemann KM. Helicobacter pylori chemotaxis modulates inflammation and bacterium-gastric epithelium interactions in infected mice. Infect Immun, 2007. doi:10.1128/IAI.00082-07.
  • Andermann TM, Chen Y-T, Ottemann KM. Two predicted chemoreceptors of Helicobacter pylori promote stomach infection. Infect Immun, 2002.
Tessa Andermann, MD, MPH